AbbVie Inc Reports Promising Results for Epcoritamab in Follicular Lymphoma Trial
HHCCX Fund | USD 14.20 0.03 0.21% |
Slightly above 61% of Highland Longshort's investor base is looking to short. The analysis of overall sentiment of trading Highland Longshort Healthcare mutual fund suggests that many investors are alarmed at this time. Highland Longshort's investing sentiment can be driven by a variety of factors including economic data, Highland Longshort's earnings reports, geopolitical events, and overall market trends.
Highland |
AbbVie Inc announced on December 7, 2024, the updated results from its Phase 1b2 EPCORE NHL-2 trial, which evaluates the investigational drug epcoritama
Read at gurufocus.com
Highland Longshort Fundamental Analysis
We analyze Highland Longshort's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Highland Longshort using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Highland Longshort based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Highland Longshort is rated below average in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Highland Longshort Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Highland Longshort mutual fund to make a market-neutral strategy. Peer analysis of Highland Longshort could also be used in its relative valuation, which is a method of valuing Highland Longshort by comparing valuation metrics with similar companies.
Peers
Highland Longshort Related Equities
HMEZX | Highland Merger | 0.05 |
| ||
HMEAX | Highland Merger | 0.05 |
| ||
HMECX | Highland Merger | 0.05 |
| ||
HHCZX | Highland Longshort | 0.12 |
| ||
HHCAX | Highland Longshort | 0.19 |
| ||
HHCCX | Highland Longshort | 0.21 |
| ||
HSZAX | Highland Small | 0.51 |
| ||
HSZYX | Highland Small | 0.59 |
| ||
HSZCX | Highland Small | 0.63 |
|
Other Information on Investing in Highland Mutual Fund
Highland Longshort financial ratios help investors to determine whether Highland Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Highland with respect to the benefits of owning Highland Longshort security.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |